UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Protocol and Rationale for the International Lung Screening Trial

Annals of the American Thoracic Society, 2020-04, Vol.17 (4), p.503-512

2020

Volltextzugriff (PDF)

Plasma pro-surfactant protein B and lung function decline in smokers

The European respiratory journal, 2015-04, Vol.45 (4), p.1037-1045

2015

Volltextzugriff (PDF)

P1.04-02 Optimizing Screening Frequency and Interval Using a Deep Learning Algorithm

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S101

2022

Volltextzugriff (PDF)

OA13.03 Evaluation of Outdoor Air Pollution Exposure (PM2.5) In Female Non-smoking Lung Cancer Patients

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S34

2022

Volltextzugriff (PDF)

MA11.08 Value of Computer Aided Diagnosis on Radiologists’ Workflow and Recommendation for Reporting Lung Cancer Screening LDCT

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S83

2022

Volltextzugriff (PDF)

EP01.07-004 FDG-PET-CT for Staging Screen Detected Lung Cancer

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S194-S195

2022

Volltextzugriff (PDF)

MA10.06 Randomized Clinical Trial with Computer Assisted Diagnosis (CAD) Versus Radiologist as First Reader of Lung Screening LDCT

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S287-S288

2019

Volltextzugriff (PDF)

MA10.01 Prospective Evaluation of the International Lung Screening Trial (ILST) Protocol for Management of First Screening LDCT

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S913-S914

2021

Volltextzugriff (PDF)

P1.11-10 Optimizing Radiomics Features by Minimizing Boundary Effects and Normalizing with Opposite Lung Tissue Characteristics

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S568-S569

2018

Volltextzugriff (PDF)

P43.02 A Multiplex Plasma Protein Panel for Detection of Lung Cancer in Ever Smokers Not Currently Eligible for Screening

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S482-S482

2021

Volltextzugriff (PDF)

FP09.01 Economic Impact of Screening Selection with the PLCOm2012 Risk Model Versus USPSTF-Guidelines in the International Lung Screening Trial (ILST)

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S211-S212

2021

Volltextzugriff (PDF)

OA06.01 Comparison Between Radiomics-Based Machine Learning and Deep Learning Image Classification for Sub-Cm Lung Nodules

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S219-S220

2019

Volltextzugriff (PDF)

MA10.01 Invasive Adenocarcinoma in Screen Detected Pure Ground-Glass Nodules (GGN)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S285-S286

2019

Volltextzugriff (PDF)

OA09.01 Opt-Out Smoking Cessation Program in Lung Cancer Screening Provides Excellent Quit Rates

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S228-S228

2019

Volltextzugriff (PDF)

OA19.01 Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S881-S881

2021

Volltextzugriff (PDF)

P2.13-012 Recruitment for Lung Cancer Screening

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2169-S2170

2017

Volltextzugriff (PDF)

OA09.07 Association Between Outdoor Air Pollution And Lung Cancer in Female Never Smokers

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S342-S342

2018

Volltextzugriff (PDF)

MA10.09 Evaluation of the Clinical Utility of the PanCan, EU-NELSON and Lung-RADS Protocols for Management of Screen Detected Lung Nodules at Baseline

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S288-S289

2019

Volltextzugriff (PDF)

PL02.02 Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S4-S5

2019

Volltextzugriff (PDF)

P2.11-23 Risk Perception Among a Lung Cancer Screening Population

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S788-S788

2018

Volltextzugriff (PDF)

MA20.01 Lung Cancer Screenee Selection by USPSTF versus PLCOm2012 Criteria – Preliminary ILST Findings

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S425-S425

2018

Volltextzugriff (PDF)

P2.13-011 Optimal Selection Criteria for LDCT Lung Cancer Screening

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2169-S2169

2017

Volltextzugriff (PDF)

MA 20.11 Chronic Obstructive Pulmonary Disease Prevalence in a Lung Cancer Screening Population

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1890-S1890

2017

Volltextzugriff (PDF)

MA03.02 Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S362-S363

2018

Volltextzugriff (PDF)

MA 14.11 Malignancy Risk Prediction of Pulmonary Nodule in Lung Cancer Screening – Diameter Or Volumetric Measurement

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1859-S1860

2017

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(20)
Female
(14)
Male
(13)
Respiratory System
(13)
Lung Cancer
(11)
Middle Aged
(11)
Oncology
(10)
Aged
(9)
Lung Neoplasms - Diagnosis
(7)
Lung Neoplasms - Diagnostic Imaging
(7)
Lung Neoplasms - Pathology
(7)
Medical Screening
(7)
Canada
(6)
Early Detection Of Cancer
(6)
General & Internal Medicine
(6)
Screening
(6)
Tomography, X-Ray Computed - Methods
(6)
Early Detection Of Cancer - Methods
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protocol and Rationale for the International Lung Screening Trial

Plasma pro-surfactant protein B and lung function decline in smokers

P1.04-02 Optimizing Screening Frequency and Interval Using a Deep Learning Algorithm

OA13.03 Evaluation of Outdoor Air Pollution Exposure (PM2.5) In Female Non-smoking Lung Cancer Patients

MA11.08 Value of Computer Aided Diagnosis on Radiologists’ Workflow and Recommendation for Reporting Lung Cancer Screening LDCT

EP01.07-004 FDG-PET-CT for Staging Screen Detected Lung Cancer

MA10.06 Randomized Clinical Trial with Computer Assisted Diagnosis (CAD) Versus Radiologist as First Reader of Lung Screening LDCT

MA10.01 Prospective Evaluation of the International Lung Screening Trial (ILST) Protocol for Management of First Screening LDCT

P1.11-10 Optimizing Radiomics Features by Minimizing Boundary Effects and Normalizing with Opposite Lung Tissue Characteristics

P43.02 A Multiplex Plasma Protein Panel for Detection of Lung Cancer in Ever Smokers Not Currently Eligible for Screening

FP09.01 Economic Impact of Screening Selection with the PLCOm2012 Risk Model Versus USPSTF-Guidelines in the International Lung Screening Trial (ILST)

OA06.01 Comparison Between Radiomics-Based Machine Learning and Deep Learning Image Classification for Sub-Cm Lung Nodules

MA10.01 Invasive Adenocarcinoma in Screen Detected Pure Ground-Glass Nodules (GGN)

OA09.01 Opt-Out Smoking Cessation Program in Lung Cancer Screening Provides Excellent Quit Rates

OA19.01 Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results

P2.13-012 Recruitment for Lung Cancer Screening

OA09.07 Association Between Outdoor Air Pollution And Lung Cancer in Female Never Smokers

MA10.09 Evaluation of the Clinical Utility of the PanCan, EU-NELSON and Lung-RADS Protocols for Management of Screen Detected Lung Nodules at Baseline

PL02.02 Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings

P2.11-23 Risk Perception Among a Lung Cancer Screening Population

MA20.01 Lung Cancer Screenee Selection by USPSTF versus PLCOm2012 Criteria – Preliminary ILST Findings

P2.13-011 Optimal Selection Criteria for LDCT Lung Cancer Screening

MA 20.11 Chronic Obstructive Pulmonary Disease Prevalence in a Lung Cancer Screening Population

MA03.02 Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol

MA 14.11 Malignancy Risk Prediction of Pulmonary Nodule in Lung Cancer Screening – Diameter Or Volumetric Measurement

Suchergebnisse filtern